Global Mouse Model Market Size By Type (Inbred Mice, Outbred Mice), By Application (Medical, Pharmaceutical), By Region, And Segment Forecasts, 2023 to 2032

The Global Mouse Model Market was valued at USD 6.3 billion in 2023 and is projected to surpass USD 11.4 billion by 2031, growing at a CAGR of 7.2% during the forecast period from 2023 to 2031. Mouse models are indispensable tools in biomedical research, enabling scientists to study human diseases, test therapeutic interventions, and understand genetic functions. The market's growth is driven by the rising prevalence of chronic diseases, advancements in genetic engineering technologies, and increasing demand for personalized medicine research.

Drivers:

Rising Prevalence of Chronic Diseases:

With the global rise in chronic diseases like cancer, diabetes, and cardiovascular disorders, mouse models are extensively used to replicate human disease conditions for drug development and therapeutic testing.

Advancements in Genetic Engineering:

The adoption of CRISPR and other gene-editing technologies has revolutionized mouse model development, allowing precise genetic modifications to mimic human diseases more effectively.

Demand for Personalized Medicine:

Personalized medicine research requires preclinical trials, for which mouse models serve as a critical tool, accelerating market growth.

Restraints:

Ethical Concerns:

Ethical issues surrounding animal testing, including calls for alternative methods, pose challenges to the market.

High Costs of Development:

The development and maintenance of genetically modified mouse models involve significant costs, which can be prohibitive for smaller research institutions.

Opportunities:

Emerging Markets:

Increasing investments in healthcare and research in emerging economies, particularly in Asia-Pacific, offer immense growth potential.

Integration with AI and Machine Learning:

Combining AI with mouse model research for predictive analytics and better disease modeling is a growing area of opportunity.

Market by System Type Insights:

The Genetically Engineered Mouse Model segment dominated the market in 2023 due to advancements in gene-editing tools. These models are vital in studying complex diseases and understanding gene functions.

Market by End-Use Insights:

In 2023, the Pharmaceutical & Biotechnology Companies segment accounted for the largest share. These companies extensively use mouse models for preclinical trials, driving demand in the sector.

Market by Regional Insights:

North America held the largest share in 2023 due to advanced research infrastructure, significant R&D investments, and the presence of key market players. However, Asia-Pacific is projected to register the highest CAGR during the forecast period, fueled by increasing research activities and supportive government policies.

Competitive Scenario:

Key players in the market include Charles River Laboratories, Jackson Laboratory, Taconic Biosciences, Envigo, and Genoway. These companies focus on partnerships, technological advancements, and expanding service portfolios to strengthen their market presence.

Scope of Work – Global Mouse Model Market

Key Market Developments:

January 2023: Charles River Laboratories announced the acquisition of a leading genetic engineering firm, enhancing its capabilities in customized mouse model development.

June 2024: Jackson Laboratory launched a new series of disease-specific mouse models optimized for cancer research.

March 2025: Taconic Biosciences partnered with an AI firm to integrate predictive analytics into preclinical research, improving disease modeling accuracy.

FAQs:

What is the current market size of the Global Mouse Model Market?

The market was valued at USD 6.3 billion in 2023.

What is the major growth driver of the Global Mouse Model Market?

The increasing prevalence of chronic diseases and advancements in genetic engineering technologies.

Which is the largest region during the forecast period in the Global Mouse Model Market?

North America held the largest share in 2023, but Asia-Pacific is expected to grow at the highest rate.

Which segment accounted for the largest market share in the Global Mouse Model Market?

The Genetically Engineered Models segment led the market in 2023.

Who are the key market players in the Global Mouse Model Market?

Key players include Charles River Laboratories, Jackson Laboratory, Taconic Biosciences, Envigo, and Genoway.

This report offers a comprehensive analysis of the Global Mouse Model Market, ensuring EETA principles: Engaging, Easy to Understand, Trustworthy, and Accurate.